预测肺癌合并特发性肺纤维化患者术后并发症的评分系统
本研究基于225例开发队列和51例验证队列,构建了预测特发性肺纤维化(IPF)合并非小细胞肺癌(NSCLC)患者术后肺部并发症(PPCs)的评分系统。最终模型纳入年龄、性别、糖尿病、美国麻醉医师协会分级、弥散功能和手术范围六个预测因子,总分0-10分。开发队列AUC为0.75(95%CI 0.69-0.82),验证队列AUC为0.73(95%CI 0.57-0.88)。
要点
- IPF合并NSCLC患者术后肺部并发症发生率为34%(95/276)。
- 评分系统包含六个易获取的临床变量,总分0-10分。
- 评分系统在开发队列和验证队列中均显示出中等 discriminative 能力。
核心结论
- 由六个易获取临床变量组成的新评分系统可能有助于预测IPF合并NSCLC患者术后肺部并发症并指导治疗决策。
研究设计与样本
- 研究分析了225例诊断为IPF并接受NSCLC根治性切除术的患者(开发队列),使用多变量逻辑回归模型开发评分系统。
- 使用独立的51例患者队列对评分进行验证,评估区分度和校准度。
主要发现
- 在分析的276例患者中,95例(34%)发生术后肺部并发症。
- 最终模型识别六个预测因子(对应分值):年龄≥65岁(1分)、男性(1分)、ASA分级≥3级(1分)、糖尿病(2分)、弥散功能≤65%(2分)、手术范围(3分),总分0-10分。
- 评分系统在开发队列中的AUC为0.75(95%CI 0.69-0.82),在验证队列中的AUC为0.73(95%CI 0.57-0.88)。
关键数值与推荐
- 年龄≥65岁(1分)、男性(1分)、ASA分级≥3级(1分)、糖尿病(2分)、弥散功能≤65%(2分)、手术范围(3分)。
临床怎么用
- 该评分系统可用于IPF合并NSCLC患者术前风险评估,辅助识别术后肺部并发症高危患者并指导治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Postoperative pulmonary complications are common and can be fatal in patients with IPF undergoing lung cancer surgery. This study aims to develop a novel scoring system for predicting postoperative pulmonary complications (PPCs) in patients with idiopathic pulmonary fibrosis (IPF) and non-small cell lung cancer (NSCLC) undergoing surgical resection and help establish optimal treatment strategies. METHODS: We analysed data from 225 patients consisting of two cohorts who were diagnosed with IPF and who underwent curative resection for NSCLC. A scoring system was developed to predict postoperative pulmonary complications based on regression coefficients derived from a multivariable logistic regression model that included the following predictors: age, sex, diabetes, American Society of Anesthesiologists, diffusing capacity, and extent of surgery. Validation of the score was assessed through discrimination and calibration using a separate cohort of 51 patients. RESULTS: Among the 276 patients analysed, 95 (34%) experienced postoperative pulmonary complications. The final model identified six predictors (with corresponding scores), resulting in a total score of 0-10 points: age ≥ 65 years (1 point), male (1 point), American Society of Anesthesiologists class ≥ 3 (1 point), diabetes (2 point), diffusing capacity ≤ 65% (2 point), and extent of surgery (3 points). The area under the curve for the scoring system was 0.75 (95% CI, 0.69-0.82) in the derivation cohort and 0.73 (95% CI, 0.57-0.88) in the validation cohort. CONCLUSIONS: This novel scoring system consisting of six easily accessible clinical variables may help predict postoperative pulmonary complications and guide treatment decisions.
引用
- Im Y, Chung MP, Kim H, et al. Predicting Postoperative Complications in Patients With Lung Cancer and Idiopathic Pulmonary Fibrosis. Respirology. 2026. PMID: 41702848. doi:10.1002/resp.70227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。